TrialPloS one2013

Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.

Micha Loebermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.